Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,509.45
(
0.48%
)
US TECH 100
29,151.96
(
1.57%
)
Dow Jones
50,397.36
(
-0.36%
)
Brent Oil
96.69
(
-4.43%
)
Bitcoin
75,767.99
(
-1.95%
)
News Focus
News Focus
Post# of 257635
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123015
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: aslan2772 post# 9616

Sunday, 04/03/2005 10:07:55 PM

Sunday, April 03, 2005 10:07:55 PM

Post# of 257635
>>I would argue that the "dirtiness" may extend beyond VEGF-specific effects. I don't think RNAi is necessarily more specific than a good ligand.<<

What kinds of off-target effects would you expect to see with an intravitreal anti-VEGF siRNA?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today